Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
Adv Ther
.
2016 Sep;33(9):1677-1678.
doi: 10.1007/s12325-016-0390-x.
Authors
Andrew Hughes
1
,
Donal Landers
2
,
Hendrik-Tobias Arkenau
3
4
,
Saj Shah
2
,
Richard Stephens
5
,
Amrik Mahal
2
,
Matthew Simmons
3
,
Charlotte Lemech
3
4
,
Jennifer Royle
6
7
Affiliations
1
Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
2
AstraZeneca, Cambridge, UK.
3
Sarah Cannon Research Institute, London, UK.
4
University College London, London, UK.
5
Consumer Forum, National Cancer Research Institute, London, UK.
6
AstraZeneca, Cambridge, UK. Jenny.Royle@cruk.manchester.ac.uk.
7
Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Jenny.Royle@cruk.manchester.ac.uk.
PMID:
27464766
PMCID:
PMC5020106
DOI:
10.1007/s12325-016-0390-x
No abstract available
Publication types
Published Erratum